View More Recent Stories
-
Equifax (EFX) call put ratio 1 call to 8.1 puts with a focus on May 210 and 230 puts as share price up 13.8%
-
Equifax (EFX) Misses Q1 EPS by 34c; offers guidance
-
Equifax (EFX) Reports Q1, Announces $3B Share Buyback, Hikes Dividend
-
BofA Securities Reinstates Equifax (EFX) at Buy
-
Barclays Downgrades Equifax (EFX) to Equalweight
-
RBC Capital Upgrades Equifax (EFX) to Outperform
-
RBC Capital 2025 Financials Conference Recap
-
Equifax (EFX) PT Lowered to $281 at Stifel
-
Equifax (EFX) PT Lowered to $300 at Needham
-
Equifax (EFX) Tops Q4 EPS by 1c; offers guidance
-
Equifax (EFX) PT Lowered to $300 at Jefferies
-
Wolfe Research Downgrades Equifax (EFX) to Peerperform
-
Morgan Stanley Upgrades Equifax (EFX) to Overweight
-
RBC is out with its 2025 Global Energy Outlook
-
Equifax (EFX) PT Lowered to $286 at Oppenheimer
-
Equifax (EFX) CEO to Stay Beyond 2025
-
After-hours movers: CSX Corp., Kinder Morgan, Alcoa and more
-
Equifax (EFX) Tops Q3 EPS by 1c, Offers Guidance
-
Equifax (EFX) PT Raised to $331 at Citi
-
Equifax (EFX) Canada Appoints Ramon Yarde as Chief Data Officer
-
Equifax (EFX) PT Raised to $315 at Oppenheimer
-
Equifax (EFX) PT Raised to $340 at Jefferies
-
UBS Starts Equifax (EFX) at Buy
-
Equifax (EFX) PT Raised to $350 at Needham, Top Pick, Remains on Needham's Conviction List
-
Needham Downgrades TransUnion (TRU) to Hold
-
Workday (WDAY) and Equifax (EFX) Announce Strategic Partnership to Modernize Employment and Income Verification Process
-
Equifax (EFX) PT Raised to $305 at Stifel
-
Equifax (EFX) PT Raised to $300 at Oppenheimer
-
Equifax (EFX) PT Raised to $320 at Needham
-
Equifax (EFX) PT Raised to $290 at Baird
-
RBC Capital Reiterates Sector Perform Rating on Equifax (EFX)
-
Equifax (EFX) PT Raised to $315 at Jefferies
-
Equifax (EFX) PT Raised to $305 at Evercore ISI
-
After-hours movers: United Airlines, Chuy's, Beyond Meat and more
-
Equifax (EFX) Tops Q2 EPS by 8c; offers guidance
-
BofA Securities Reiterates Buy Rating on Equifax (EFX)
-
Facebook's Zuckerberg faces Senate hearing but little hope for action

